Evidence map›Paper›PMID 34863172›Full record

ArticleMalaria journal2021

Determinants of malaria testing at health facilities: the case of Uganda.

Ruth N Kigozi, JohnBaptist Bwanika, Emily Goodwin, Peter Thomas, Patrick Bukoma, Persis Nabyonga, Fred Isabirye, Paul Oboth, Carol Kyozira, Mame Niang and 4 more

Abstract read
In one paragraph

Article in Malaria journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ruth N KigoziMAPD Project, US President's Malaria Initiative, Kampala, Uganda. kigoziruth@gmail.com.ORCID http://orcid.org/0000-0003-2834-2670
JohnBaptist BwanikaMAPD Project, US President's Malaria Initiative, Kampala, Uganda.
Emily GoodwinMAPD Project, US President's Malaria Initiative, Kampala, Uganda.
Peter ThomasMalaria Branch, Centers for Disease Control and Prevention, US President's Malaria Initiative, Atlanta, GA, 30329, USA.
Patrick BukomaMAPD Project, US President's Malaria Initiative, Kampala, Uganda.
Persis NabyongaMAPD Project, US President's Malaria Initiative, Kampala, Uganda.
Fred IsabiryeMAPD Project, US President's Malaria Initiative, Kampala, Uganda.
Paul ObothInfectious Disease Institute, Kampala, Uganda.
Carol KyoziraMinistry of Health, Kampala, Uganda.
Mame NiangMalaria Branch, Centers for Disease Control and Prevention, US President's Malaria Initiative, Kampala, Uganda.
Kassahun BelayUS President's Malaria Initiative, US Agency for International Development, Kampala, Uganda.
Gloria SebikaariUS President's Malaria Initiative, US Agency for International Development, Kampala, Uganda.
James K TibenderanaMalaria Consortium, London, UK.
Sam Siduda GudoiMAPD Project, US President's Malaria Initiative, Kampala, Uganda.

Funding

US President's Malaria Initiative AID-617-C-16-00001
6 · The paper itself

Abstract

backgroundThe World Health Organization (WHO) recommends prompt malaria diagnosis with either microscopy or malaria rapid diagnostic tests (RDTs) and treatment with an effective anti-malarial, as key interventions to control malaria. However, in sub-Saharan Africa, malaria diagnosis is still often influenced by clinical symptoms, with patients and care providers often interpreting all fevers as malaria. The Ministry of Health in Uganda defines suspected malaria cases as those with a fever. A target of conducting testing for at least 75% of those suspected to have malaria was established by the National Malaria Reduction Strategic Plan 2014-2020.

methodsThis study investigated factors that affect malaria testing at health facilities in Uganda using data collected in March/April 2017 in a cross-sectional survey of health facilities from the 52 districts that are supported by the US President's Malaria Initiative (PMI). The study assessed health facility capacity to provide quality malaria care and treatment. Data were collected from all 1085 public and private health facilities in the 52 districts. Factors assessed included supportive supervision, availability of malaria management guidelines, laboratory infrastructure, and training health workers in the use of malaria rapid diagnostic test (RDT). Survey data were matched with routinely collected health facility malaria data obtained from the district health information system Version-2 (DHIS2). Associations between testing at least 75% of suspect malaria cases with several factors were examined using multivariate logistic regression.

resultsKey malaria commodities were widely available; 92% and 85% of the health facilities reported availability of RDTs and artemether-lumefantrine, respectively. Overall, 933 (86%) of the facilities tested over 75% of patients suspected to have malaria. Predictors of meeting the testing target were: supervision in the last 6 months (OR: 1.72, 95% CI 1.04-2.85) and a health facility having at least one health worker trained in the use of RDTs (OR: 1.62, 95% CI 1.04-2.55).

conclusionThe study findings underscore the need for malaria control programmes to provide regular supportive supervision to health facilities and train health workers in the use of RDTs.

Indexed as

AntimalarialsArtemether, Lumefantrine Drug CombinationCross-Sectional StudiesDiagnostic Tests, RoutineHealth FacilitiesHumansMalariaUgandaAntimalarialsArtemether, Lumefantrine Drug CombinationMalariaMalaria diagnostic practices

Identifiers

PMID34863172
PMCPMC8645102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.